SUNY-Buffalo: New Drug May Protect Against Memory Loss in Alzheimer's Disease
September 10, 2019
September 10, 2019
BUFFALO, New York, Sept. 10 [TNSmedicalresearch] -- The State University of New York's Buffalo Campus issued the following news release:
* * *
- The drug is now in Phase 2 clinical trials in patients with Alzheimer's and Fragile X syndrome
* * *
A new drug discovered through a research collaboration between the University at Buffalo and Tetra Therapeutics may protect against memory loss, nerve damage and other symptoms of Alzheimer's disease.
* * *
- The drug is now in Phase 2 clinical trials in patients with Alzheimer's and Fragile X syndrome
* * *
A new drug discovered through a research collaboration between the University at Buffalo and Tetra Therapeutics may protect against memory loss, nerve damage and other symptoms of Alzheimer's disease.